STAT reports that four editors of the American Diabetes Association’s flagship journal Diabetes Care have announced they will no longer review manuscript submissions as part of a boycott of the ADA. The action follows the June removal of several members from an ADA conference center in New Orleans, where they had been handing out copies of an editorial about federal research funding cuts. The editors who stepped back from review duties are Steven Kahn (editor-in-chief of Diabetes Care), Cheryl Anderson (UC San Diego), John Buse (University of North Carolina), and Elizabeth Selvin (Johns Hopkins).
According to the report, the expulsions, the ADA leadership’s immediate handling of the incident, and a subsequent summer-long review prompted members to organize the boycott. Steven Kahn characterized the move to STAT as effectively “a strike against a major corporation,” framing the dispute as members pushing back against what they see as corporate-style governance by ADA leadership. An ADA spokesperson told STAT that the organization is aware of the efforts and remains focused on serving people who rely on the ADA’s mission. The source did not provide further details on the terms of the boycott, the duration, or whether other journal activities would be affected beyond the refusal to review manuscripts.
The round-up notes that President Trump announced plans to send $500 refund checks to nearly 1 million people enrolled in Affordable Care Act plans who do not receive federal subsidies and live predominantly in federal marketplace states. The payments are intended for enrollees in about 30 states that use the federal ACA marketplace. The story highlights that eligibility specifics — for example whether only current enrollees or also former planholders qualify — remain unclear in the reporting, and colleagues at STAT have written separately about the uncertain legality of the payments. The White House framed the payments as relief for those affected by the expiration of enhanced ACA premium support.
STAT covered a rare FDA de novo classification issued to an artificial intelligence algorithm from Powerful Medical called Queen of Hearts. The device is intended to analyze EKGs to detect patterns consistent with the most severe type of heart attack — a complete coronary artery blockage often identified as an ST-Elevation Myocardial Infarction (STEMI) pattern — and help triage patients presenting with chest pain so they receive timely treatment to restore blood flow.
The article notes that most AI medical devices reach market through the FDA’s 510(k) process, while de novo classifications are less common and typically require more clinical evidence. STAT referenced additional reporting on what the algorithm could mean for faster detection of STEMI by clinicians and for patient care, without providing new clinical data or performance metrics beyond the regulatory milestone.
STAT summarized a study published in Science examining long-term effects of platinum-based chemotherapy in children treated for hepatoblastoma, a rare pediatric liver cancer. Researchers compared healthy and cancerous liver tissue and blood from children exposed to platinum agents with samples from children given other treatments. The analysis found hundreds of mutations in tissues exposed to platinum, mutations typically seen in adult livers. In the source account, investigators interpreted this pattern as evidence that platinum therapy can accelerate the molecular aging of liver cells in treated children.
The reporting emphasizes that platinum compounds can be life-saving for certain childhood cancers but may carry long-term risks that warrant attention to monitoring and future care planning. STAT pointed readers to its colleague’s full report for more detail on the implications for survivorship and follow-up, while the newsletter itself did not provide granular study methods or quantitative mutation counts beyond the summary.
An investigation into a community outbreak of methicillin-resistant Staphylococcus aureus (MRSA) in eastern Ireland traced roughly four dozen pediatric cases to a community party in August 2025 where children spent extended time in three bouncy castles. About 120 people attended the event; children later developed skin and soft tissue lesions and abscesses. Approximately one-quarter of cases experienced systemic symptoms such as fever, nausea, or vomiting. Four infected children were hospitalized; all recovered. One additional child who had not attended the party became infected through close contact with an attendee.
Irish public health officials reported this outbreak in the online journal Eurosurveillance, and STAT described it as the largest MRSA outbreak on record in Ireland. The newsletter presented the investigation as an example of how commonplace recreational environments may facilitate spread of skin infections when multiple children have prolonged contact with shared surfaces.
The round-up closes with suggested related reading from STAT and other outlets, including an opinion piece on pro-vaccine advocacy, reporting on a cyclosporiasis outbreak, and coverage of AI safeguards against misuse. STAT’s Morning Rounds authors for this edition are Chelsea Cirruzzo, Helen Branswell, and Elizabeth Cooney; their bios and beats are noted in the source.
Note: All facts and quotes in this summary are drawn from the STAT Morning Rounds article published Sept. 11, 2026. Where the STAT piece did not report details (for example, the specific terms, scope, or duration of the ADA boycott; legal determinations about ACA refund payments; or detailed performance metrics for the FDA-cleared algorithm), this rewrite does not supply additional information.